Performance

AVLN +0.03%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
AVLN	+1.20%	+0.03%*	+0.03%*	—	-40.56%*	0.26*	0.00%*

Summary

AVLN at a glance

AVLN returned +0.03% since Apr 30, 2026. Its worst drop since then was -40.56%, smaller than 37% of stocks on Redstone, and its Sharpe ratio of 0.26 beats 39% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How AVLN ranks

Dividend Yield Rank *

Current Drawdown

-24.84%

Rolling Volatility

64.65%

Actions

Metrics

Risk Indicators*

Alpha15.53%

Beta0.19x

Sharpe0.26

Sortino0.38

Omega1.04

Calmar0.00

Martin0.90

Profile

About AVLN

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs).

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.3B
Listed: Apr 2026
Headquarters: Boston, MA
Website: avalynpharma.com

Comparisons

AVLN: Avalyn Pharma Inc.

AVLN at a glance

How AVLN ranks

Current Drawdown

Rolling Volatility

About AVLN

Related comparisons